Breaking Down Eastman Chemical: 9 Analysts Share Their Views

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Eastman Chemical (NYSE:EMN) in the last three months.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	2	6	1	0	0
Last 30D	0	1	0	0	0
1M Ago	0	0	0	0	0
2M Ago	1	4	1	0	0
3M Ago	1	1	0	0	0

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $78.89, a high estimate of $101.00, and a low estimate of $65.00. A decline of 14.04% from the prior average price target is evident in the current average.

Diving into Analyst Ratings: An In-Depth Exploration

A clear picture of Eastman Chemical's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Michael Sison	Wells Fargo	Raises	Overweight	$80.00	$70.00
Duffy Fischer	Goldman Sachs	Lowers	Neutral	$65.00	$87.00
Arun Viswanathan	RBC Capital	Lowers	Outperform	$74.00	$91.00
Patrick Cunningham	Citigroup	Lowers	Buy	$68.00	$90.00
Aleksey Yefremov	Keybanc	Lowers	Overweight	$79.00	$93.00
Michael Sison	Wells Fargo	Lowers	Overweight	$70.00	$90.00
John Roberts	Mizuho	Lowers	Outperform	$80.00	$92.00
Scott Schoenhaus	Keybanc	Lowers	Overweight	$93.00	$106.00
Joshua Spector	UBS	Lowers	Buy	$101.00	$107.00

Key Insights:

• Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Eastman Chemical. This information offers a snapshot of how analysts perceive the current state of the company.
• Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Eastman Chemical compared to the broader market.
• Price Targets: Delving into movements, analysts provide estimates for the future value of Eastman Chemical's stock. This analysis reveals shifts in analysts' expectations over time.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Eastman Chemical's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Eastman Chemical analyst ratings.

Get to Know Eastman Chemical Better

Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.

Key Indicators: Eastman Chemical's Financial Health

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Revenue Growth: Eastman Chemical's revenue growth over a period of 3M has faced challenges. As of 30 June, 2025, the company experienced a revenue decline of approximately -3.22%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.

Net Margin: Eastman Chemical's net margin excels beyond industry benchmarks, reaching 6.12%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): Eastman Chemical's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.39% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Eastman Chemical's ROA excels beyond industry benchmarks, reaching 0.93%. This signifies efficient management of assets and strong financial health.

Debt Management: Eastman Chemical's debt-to-equity ratio is below the industry average. With a ratio of 0.88, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

Analyst Ratings: What Are They?

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.